Adaptive Designs and Orphan Diseases

Building A Bridge of Innovation

Michael Murphy, MD, PhD

Does your targeted rare indication have diverse expressions of pathology? Is your patient population small? Do you need to account for the differences in genetic and phenotypic expression in your patient population?

Adaptive study designs may be good fit for your study because they allow for a greater flexibility when evaluating your product. However, they are operationally complex and require experienced teams to mitigate risk.

Learn more about how to execute a successful adaptive study design:

Your form has been successfully submitted! Click the button below to access.
READ MORE
Michael Murphy, MD, PhD
MEET THE AUTHOR

Michael Murphy, MD, PhD

Chief Medical and Scientific Officer
LEARN MORE